Tomonori Kawaguchi Selected Research

Tomonori Kawaguchi Research Topics

Disease

6	Heart Failure 01/2021 - 11/2010
5	Fibrosis (Cirrhosis) 01/2019 - 10/2009
4	Myocardial Infarction 05/2014 - 10/2009
3	Hypertrophy 01/2019 - 11/2010
3	Infarction (Infarctions) 07/2015 - 10/2009
3	Starvation 12/2012 - 05/2009
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 03/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2018
2	Sepsis (Septicemia) 01/2019 - 01/2018
2	Endotoxemia 01/2019 - 01/2018
2	Cardiotoxicity 12/2012 - 02/2010
2	Inflammation (Inflammations) 03/2012 - 02/2010
2	Hypoxia (Hypoxemia) 06/2011 - 08/2010
2	Anemia 11/2010 - 08/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2022
1	Diabetic Cardiomyopathies 01/2021
1	Hypertension (High Blood Pressure) 11/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Diabetes Mellitus 01/2019
1	Vascular System Injuries 11/2018
1	Lactic Acidosis 09/2018
1	Shock 09/2018
1	Acidosis 09/2018
1	Torsades de Pointes (Torsade de Pointes) 09/2012
1	Left Ventricular Dysfunction 03/2012
1	Cardiomegaly (Heart Hypertrophy) 07/2011
1	Ischemia 04/2011
1	Peripheral Arterial Disease 04/2011
1	Necrosis 06/2009

Drug/Important Bio-Agent (IBA)

3	LipopolysaccharidesIBA 01/2019 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2012 - 02/2010
3	Green Fluorescent ProteinsIBA 12/2012 - 05/2009
3	Adenosine Triphosphate (ATP)IBA 12/2012 - 05/2009
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2012 - 05/2009
3	Erythropoietin FDA Link 03/2012 - 08/2010
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 09/2018
2	Sarcoglycans (beta Sarcoglycan)IBA 01/2019 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 08/2010
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2015 - 04/2011
2	Cathepsin DIBA 12/2012 - 05/2009
2	asialoerythropoietinIBA 03/2012 - 11/2010
2	bafilomycin A1IBA 06/2011 - 05/2009
2	Amino Acids FDA Link 06/2011 - 05/2009
1	LipidsIBA 03/2022
1	GlycogenIBA 01/2021
1	miglitol (Glyset)FDA Link 11/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019
1	SaltsIBA 11/2019
1	GlucosidasesIBA 11/2019
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	CytokinesIBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2018
1	Bicarbonates (Hydrogen Carbonate)IBA 09/2018
1	TabletsIBA 09/2018
1	Dialysis SolutionsIBA 09/2018
1	SugarsIBA 01/2018
1	Bevacizumab (Avastin)FDA Link 07/2015
1	Chloroquine (Aralen)FDA LinkGeneric 03/2013
1	ResveratrolIBA 03/2013
1	AntioxidantsIBA 03/2013
1	Adenylate KinaseIBA 03/2013
1	AMP-Activated Protein KinasesIBA 12/2012
1	Phosphotransferases (Kinase)IBA 12/2012
1	Autophagy-Related Protein-1 HomologIBA 12/2012
1	Amiodarone (Amiodarona)FDA LinkGeneric 09/2012
1	Atrial Natriuretic Factor (ANF)IBA 07/2011
1	GelatinIBA 04/2011
1	HydrogelsIBA 04/2011
1	DNA (Deoxyribonucleic Acid)IBA 11/2010
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 11/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2010
1	Fas Ligand Protein (Fas Ligand)IBA 02/2010
1	DecorinIBA 10/2009
1	Oxidants (Oxidizing Agents)IBA 06/2009
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 06/2009
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2009
1	Autophagy-Related ProteinsIBA 05/2009
1	UbiquitinIBA 05/2009
1	Acid PhosphataseIBA 05/2009

Therapy/Procedure

6	Ligation 07/2015 - 10/2009
1	Percutaneous Coronary Intervention 03/2022
1	Intravenous Administration 09/2018
1	Hemodiafiltration 09/2018
1	Intraperitoneal Injections 12/2012
1	Microspheres (Microsphere) 04/2011
1	Nephrectomy 11/2010
1	Intramuscular Injections 02/2010